<DOC>
	<DOCNO>NCT02585609</DOCNO>
	<brief_summary>The primary focus clinical study objective subjective measurement sleep quality patient advance cancer use opioids . It also examine sleep disturbance association sleep quality symptom order improve symptom management patient advance cancer . The overall aim study improve clinical understanding sleep quality patient advance cancer use opioids improve understand sleep quality may best measure order improve symptom management .</brief_summary>
	<brief_title>Sleep Quality Patients With Advanced Cancer</brief_title>
	<detailed_description />
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<criteria>A verified diagnosis malignant disease Presence metastatic/disseminated disease Regularly schedule oral , subcutaneous , transdermal intravenous opioid treatment correspond step III WHO pain ladder duration treatment le 3 day Able comply study procedure Signed informed consent accord ICH Good Clinical Practice national/local regulation Not consent participation Not master language use study centre Severe cognitive impairment judge principal investigator Any reason , opinion investigator , patient participate Impaired use dominant arm Local anatomical illness abnormality preclude use polysomnography ( e.g . facial tumour ) receive chemotherapy 4 week , receive previous dose less 5 day ago receive next dose within study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Sleep</keyword>
</DOC>